A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/122 (2006.01) A61K 31/175 (2006.01) A61K 31/70 (2006.01) A61K 31/7004 (2006.01) A61P 9/10 (2006.01) A61P 25/00 (2006.01)
Patent
CA 2368850
The present invention relates to the use of beta--naphthoquinone derivatives, and salts thereof, for the prevention and /or the treatment of glutamate cytotoxicity. It further relates to the use of beta--naphthoquinone derivatives, and salts thereof, for preventing and/or treating glutamate induced neurological disorders. Additionally, it concerns the use of beta-naphthoquinone derivatives, and salts thereof, for making drugs exerting an inhibitory effect on the release of glutamate.
La présente invention porte sur l'utilisation de dérivés de la bêta naphthoquinone et de ses sels pour la prévention et/ou le traitement de la cytotoxicité au glutamate. L'invention concerne aussi l'utilisation des dérivés de la bêta naphthoquinone et de ses sels pour prévenir et/ou traiter les troubles neurologiques induits par le glutamate. En outre, l'invention divulgue l'utilisation des dérivés de la bêta naphthoquinone et de ses sels pour fabriquer des médicaments ayant un effet inhibiteur sur la libération du glutamate.
Bloy Christian
Israel Maurice
Mattei Cesar
Molgo Jordi
Centre National de La Recherche Scientifique
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Methods for the prevention and/or the treatment of glutamate... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the prevention and/or the treatment of glutamate..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the prevention and/or the treatment of glutamate... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1876783